Grasim Industries Limited (GRASIM) — Financial Results | 10 February 2025(4 announcements)

Grasim Industries reported consolidated revenue of ₹34,793 crores, up 9% YoY for Q3FY25, driven by growth across businesses, though PAT declined 40% YoY to ₹899 crores due to lower cement realisations, initial paint investments, and higher financing costs.

Grasim Industries reported consolidated revenue of ₹34,793 crores in Q3FY25, up 9% YoY, but consolidated EBITDA declined 9% YoY to ₹4,668 crores due to margin pressure in cement and strategic investments. Consolidated PAT stood at ₹3,867 crores, with net debt to EBITDA improving to 1.64x as of December 2024. The company expanded cellulosic fibres capacity with an 110K TPA Lyocell plant and advanced its paints and financial services growth initiatives.

Grasim Industries reported consolidated revenue of ₹1,02,216.45 crores for the nine months ended 31 December 2024, reflecting a 9.2% YoY increase from ₹93,635.77 crores in the same period last year. Net profit from continuing operations rose to ₹5,212.20 crores, up from ₹4,876.58 crores YoY, driven by improved operating margins and lower effective tax rates. The company completed the acquisition of a controlling stake in India Cements Limited in December 2024, finalizing the scheme of arrangement and open offer acceptance. Regulatory approvals from SEBI, CCI, and NCLT were secured, enabling integration. The filing also noted reclassification adjustments and tax impacts affecting comprehensive income. Key financial ratios showed stable leverage, with a debt-equity ratio of 0.23 and current ratio of 1.50 as of December 2024.

Grasim Industries reported a 69.9% YoY revenue jump to ₹35,154.68 crores for Q3 FY25, driven by strong segment performance and strategic acquisitions, though net profit declined 16.8% YoY to ₹898.97 crores due to higher expenses and tax outflows. The company finalized the acquisition of India Cements, boosting consolidated control to 81.49%, while maintaining a healthy current ratio of 1.50 and debt-equity of 0.23. Board-approved results reflect robust top-line growth amid operational restructuring and regulatory milestones.